API | autologous peripheral blood mononuclear cells

autologous peripheral blood mononuclear cells Report issue

Cell therapy Experimental

AACT

Active Ingredient History

NOW

Peripheral blood cells are the cellular components of blood, consisting of red blood cells (erythrocytes), white blood cells (leucocytes), and platelets, which are found within the circulating pool of blood and not sequestered within the lymphatic system, spleen, liver, or bone marrow. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

autologous pbmc | autologous pbmcs | autologous peripheral blood lymphocytes | autologous peripheral blood mononuclear cells | autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous cd54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor | peripheral blood cells | peripheral blood derived mononuclear cells | peripheral blood mononuclear cell | peripheral blood mononuclear cells

Organizations (38)

Research & Development (38)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (42)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (42)

Allogeneic Cells (Phase 2)

Anemia, Sickle Cell (Phase 1/Phase 2)

Angina Pectoris (Phase 2)

Atherosclerosis (Phase 3)

Cartilage Diseases (Phase 2)

Cerebral Palsy (Phase 1/Phase 2)

Chest Pain (Phase 1/Phase 2)

Chronic Limb-Threatening Ischemia (Phase 3)

Coronary Artery Disease (Phase 1/Phase 2)

Diabetic Foot (Phase 1/Phase 2)

Enterocolitis, Neutropenic (Phase 1/Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Gangrene (Phase 3)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Graft vs Host Disease (Phase 2)

Granulocyte Colony-Stimulating Factor (Phase 1/Phase 2)

Hamartoma (Phase 2)

Healthy Volunteers (Phase 1)

Hematologic Neoplasms (Phase 1/Phase 2)

Ischemia (Phase 1/Phase 2)

Kidney Failure, Chronic (Phase 1/Phase 2)

Leg Ulcer (Phase 1/Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1/Phase 2)

Leukemia, Myeloid, Acute (Phase 1/Phase 2)

Leukocytes, Mononuclear (Phase 1/Phase 2)

Lymphoma, Non-Hodgkin (Phase 1)

Melanoma (Phase 3)

Multiple Myeloma (Phase 1/Phase 2)

Myelodysplastic Syndromes (Phase 1/Phase 2)

Myocardial Infarction (Phase 1/Phase 2)

Myocardial Ischemia (Phase 2)

Neoplasms (Phase 1/Phase 2)

Neurodegenerative Diseases (Phase 2)

Ovarian Neoplasms (Phase 2)

Pain (Phase 2)

Peripheral Vascular Diseases (Phase 1/Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1/Phase 2)

Prostheses and Implants (Phase 2)

Ulcer (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 26
# of Trial Organizations: 38

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue